Detalhe da pesquisa
1.
Morbidity-mortality conference for adverse events associated with totally implanted venous access for cancer chemotherapy.
Support Care Cancer
; 24(4): 1857-63, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26454864